rs34367357
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001366385.1(CARD14):c.1753G>A(p.Val585Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0794 in 1,613,510 control chromosomes in the GnomAD database, including 5,603 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign,association (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Synonymous variant affecting the same amino acid position (i.e. V585V) has been classified as Likely benign.
Frequency
Consequence
NM_001366385.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CARD14 | NM_001366385.1 | c.1753G>A | p.Val585Ile | missense_variant | 16/24 | ENST00000648509.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CARD14 | ENST00000648509.2 | c.1753G>A | p.Val585Ile | missense_variant | 16/24 | NM_001366385.1 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0672 AC: 10222AN: 152220Hom.: 407 Cov.: 32
GnomAD3 exomes AF: 0.0872 AC: 21892AN: 250978Hom.: 1229 AF XY: 0.0852 AC XY: 11567AN XY: 135788
GnomAD4 exome AF: 0.0807 AC: 117862AN: 1461172Hom.: 5200 Cov.: 32 AF XY: 0.0802 AC XY: 58326AN XY: 726914
GnomAD4 genome ? AF: 0.0671 AC: 10222AN: 152338Hom.: 403 Cov.: 32 AF XY: 0.0686 AC XY: 5112AN XY: 74490
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 22% of patients studied by a panel of primary immunodeficiencies. Number of patients: 21. Only high quality variants are reported. - |
Pityriasis rubra pilaris;C1864497:Psoriasis 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2018 | This variant is associated with the following publications: (PMID: 32725812) - |
Pityriasis rubra pilaris Other:1
association, criteria provided, single submitter | clinical testing | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | CARD14 is a scaffold protein that mediates NF-κB signal transduction in skin keratinocytes. Potent mutations in Card14 have been shown to be associated with familial pustular psoriasis and other cutaneous inflammatory conditions like Pytriasis rubra pilaris. Sufficient evidence is found to confer the association of this particular variant rs34367357 with psoriasis - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at